-tecan
A topoisomerase I inhibitor, a cancer drug; several are the payloads of antibody-drug conjugates.
- Drugs ending in -tecan: 21
- Approved somewhere: 2
- With a US drug page: 2
- Stem
- -tecan
- Class
- Cancer drugs that block topoisomerase I, like irinotecan
- Most common targets
- TOP1 (11)
Approved and clinical-stage drugs in ChEMBL whose names ending in -tecan, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Irinotecan | Approved | TOP1 | DNA topoisomerase I inhibitor |
| Topotecan | Approved | TOP1 | DNA topoisomerase I inhibitor |
| Belotecan | Phase 3 | TOP1 | DNA topoisomerase I inhibitor |
| Etirinotecan pegol | Phase 3 | TOP1 | DNA topoisomerase I inhibitor |
| Exatecan | Phase 3 | TOP1 | DNA topoisomerase I inhibitor |
| Irinotecan sucrosofate | Phase 3 | TOP1 | DNA topoisomerase I inhibitor |
| Rubitecan | Phase 3 | TOP1 | DNA topoisomerase I inhibitor |
| Afeletecan | Phase 2 | TOP1 | DNA topoisomerase I stabiliser |
| Davamotecan pegadexamer | Phase 2 | — | — |
| Diflomotecan | Phase 2 | TOP1 | DNA topoisomerase I inhibitor |
| Firtecan pegol | Phase 2 | — | — |
| Gimatecan | Phase 2 | TOP1 | DNA topoisomerase I inhibitor |
| Lurtotecan | Phase 2 | — | — |
| Orenasitecan | Phase 2 | — | — |
| Pegamotecan | Phase 2 | — | — |
| Deruxtecan | Phase 1 | — | — |
| Mureletecan | Phase 1 | TOP1 | DNA topoisomerase I inhibitor |
| Pamirtecan | Phase 1 | — | — |
| Samrotecan | Phase 1 | — | — |
| Simmitecan free base | Phase 1 | — | — |
| Tenifatecan | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO